Iris Schrader
Impact in
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Cancer Research top 2%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
Papers in
-
- Breast Cancer Treatment Studies 11
- Cancer Genomics and Diagnostics 2
- Oncology 13
- HER2/EGFR in Cancer Research 5
- Cancer Cells and Metastasis 4
- Cancer Treatment and Pharmacology 3
- Co-authors
- Sibylle Loibl (11 shared papers)Gϋnter von Minckwitz (10 shared papers)Martina Komor (2 shared papers)Marc Roller (2 shared papers)Christine Solbach (4 shared papers)Claus Alexander Hanusch (5 shared papers)Silvia Darb‐Esfahani (2 shared papers)Carsten Denkert (2 shared papers)
- Journals
- Breast Care (4 papers)European Journal of Cancer (3 papers)Clinical Cancer Research (3 papers)Breast Cancer Research and Treatment (2 papers)Annals of Oncology (2 papers)
- Partner nations
- GermanySwitzerlandCuracao
In The Last Decade
Iris Schrader
27 papers receiving 3.3k citations
Iris Schrader's Hit Papers
Peers
Comparison fields: 5 of 88
- Oncology 2.1k
- Cancer Research 1.2k
- Immunology 607
- Pulmonary and Respiratory Medicine 424
- Pathology and Forensic Medicine 145
Countries citing papers authored by Iris Schrader
This map shows the geographic impact of Iris Schrader's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iris Schrader with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iris Schrader more than expected).
Fields of papers citing papers by Iris Schrader
This network shows the impact of papers produced by Iris Schrader. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iris Schrader. The network helps show where Iris Schrader may publish in the future.
Co-authors
The 25 scholars most cited alongside Iris Schrader, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer Hit paper breakdown → | 2009 | 1470 |
| 2 | 2010 | 430 | |
| 3 | Neoadjuvant Chemotherapy and Bevacizumab for HER2-Negative Breast Cancer Hit paper breakdown → | 2012 | 429 |
| 4 | 2013 | 195 | |
| 5 | 2013 | 120 | |
| 6 | 2014 | 110 | |
| 7 | 2017 | 95 | |
| 8 | 2013 | 92 | |
| 9 | 2017 | 87 | |
| 10 | 2005 | 82 | |
| 11 | 2011 | 46 | |
| 12 | 2017 | 44 | |
| 13 | 2021 | 38 | |
| 14 | 2010 | 33 | |
| 15 | 2020 | 22 | |
| 16 | 2013 | 22 | |
| 17 | 2014 | 19 | |
| 18 | 2022 | 13 | |
| 19 | 2020 | 12 | |
| 20 | 2014 | 9 |
About Iris Schrader
Iris Schrader is a scholar working on Cancer Research, Oncology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Genetics, having authored 28 papers that have together received 3.4k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (11 papers), HER2/EGFR in Cancer Research (5 papers), Cancer Cells and Metastasis (4 papers), Cancer Treatment and Pharmacology (3 papers), Cancer Genomics and Diagnostics (2 papers), Advanced Breast Cancer Therapies (2 papers), Lung Cancer Treatments and Mutations (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). The work is most often cited by research in Oncology (2.1k citations), Cancer Research (1.2k citations), Immunology (607 citations), Pulmonary and Respiratory Medicine (424 citations) and Pathology and Forensic Medicine (145 citations). Iris Schrader has collaborated with scholars based in Germany, Switzerland and Curacao. Frequent co-authors include Sibylle Loibl, Gϋnter von Minckwitz, Martina Komor, Marc Roller, Christine Solbach, Claus Alexander Hanusch, Silvia Darb‐Esfahani, Carsten Denkert, Ralf Kronenwett and Christian von Törne. Their work appears in journals such as Breast Care, European Journal of Cancer, Clinical Cancer Research, Breast Cancer Research and Treatment and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.